Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

CIRESI, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.273
EU - Europa 5.098
AS - Asia 4.441
SA - Sud America 722
AF - Africa 141
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 5
Totale 20.690
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.110
SG - Singapore 1.575
IT - Italia 1.533
CN - Cina 1.240
RU - Federazione Russa 1.063
BR - Brasile 541
FI - Finlandia 540
VN - Vietnam 382
HK - Hong Kong 376
DE - Germania 375
PL - Polonia 264
FR - Francia 259
UA - Ucraina 250
IE - Irlanda 249
GB - Regno Unito 217
JP - Giappone 149
KR - Corea 143
BD - Bangladesh 117
SE - Svezia 97
IN - India 82
TR - Turchia 82
CA - Canada 73
AR - Argentina 70
NL - Olanda 46
MX - Messico 43
CI - Costa d'Avorio 40
IQ - Iraq 40
RO - Romania 36
ES - Italia 33
AT - Austria 32
BE - Belgio 32
CL - Cile 32
PK - Pakistan 30
ZA - Sudafrica 27
NP - Nepal 24
UZ - Uzbekistan 21
AE - Emirati Arabi Uniti 19
SA - Arabia Saudita 19
MA - Marocco 18
MY - Malesia 18
EC - Ecuador 17
ID - Indonesia 17
CO - Colombia 16
KE - Kenya 15
PH - Filippine 15
PY - Paraguay 15
JO - Giordania 13
CZ - Repubblica Ceca 12
IR - Iran 12
TN - Tunisia 12
UY - Uruguay 12
CH - Svizzera 11
VE - Venezuela 11
JM - Giamaica 10
AL - Albania 9
LB - Libano 9
AU - Australia 8
CR - Costa Rica 8
DZ - Algeria 8
EG - Egitto 8
BG - Bulgaria 7
GR - Grecia 7
IL - Israele 7
PE - Perù 7
SY - Repubblica araba siriana 7
TH - Thailandia 7
TW - Taiwan 7
HN - Honduras 6
LT - Lituania 6
DK - Danimarca 5
AM - Armenia 4
AZ - Azerbaigian 4
BH - Bahrain 4
DO - Repubblica Dominicana 4
KZ - Kazakistan 4
MK - Macedonia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
GT - Guatemala 3
NI - Nicaragua 3
OM - Oman 3
PA - Panama 3
SN - Senegal 3
SV - El Salvador 3
AO - Angola 2
BB - Barbados 2
BS - Bahamas 2
BY - Bielorussia 2
CY - Cipro 2
EU - Europa 2
GE - Georgia 2
KG - Kirghizistan 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
BA - Bosnia-Erzegovina 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
ET - Etiopia 1
Totale 20.674
Salva come PNG Salva come JPEG
Città #
Ashburn 1.165
Fairfield 1.162
Singapore 984
San Jose 627
Woodbridge 594
Wilmington 529
Houston 510
Seattle 468
Chandler 454
Cambridge 380
Hong Kong 364
Ann Arbor 334
Council Bluffs 318
Dublin 249
Zgierz 227
Medford 197
Moscow 195
Beijing 189
Des Moines 169
Palermo 154
Tokyo 147
Jacksonville 141
Nanjing 132
Santa Clara 129
Princeton 125
Helsinki 121
Los Angeles 121
New York 119
Ho Chi Minh City 112
Hanoi 110
Lauterbourg 110
Dallas 109
Boardman 102
Frankfurt am Main 100
Dearborn 84
Altamura 80
San Diego 69
Milan 64
Chicago 62
Changsha 58
Lawrence 55
Jinan 54
Nanchang 51
Rome 51
Tulsa 50
Atlanta 47
Tianjin 46
Hebei 45
Phoenix 45
São Paulo 44
Izmir 41
Jiaxing 41
Abidjan 40
Buffalo 39
The Dalles 38
Seongnam 37
Shenyang 36
London 33
Brussels 30
Ludwigshafen am Rhein 30
Ningbo 30
Falls Church 28
Zhengzhou 27
Orem 26
Redwood City 25
Santiago 25
Da Nang 24
Guangzhou 24
Nuremberg 23
Saint Petersburg 22
Hefei 21
Rio de Janeiro 21
Montreal 20
Columbus 19
Denver 19
Munich 19
Baghdad 17
Kumar 17
Amsterdam 16
Hangzhou 16
Johannesburg 16
Shanghai 15
Taizhou 15
Toronto 15
Basingstoke 14
Bucheon-si 14
Frankfurt 14
Guarulhos 14
Tashkent 14
Vienna 14
Warsaw 14
Amman 13
Auburn Hills 13
Naples 13
San Paolo di Civitate 13
Brooklyn 12
Chennai 12
City of London 12
Florence 12
Nairobi 12
Totale 12.927
Salva come PNG Salva come JPEG
Nome #
The Daily Consumption of Cola Can Determine Hypocalcemia: A Case Report of Postsurgical Hypoparathyroidism-Related Hypocalcemia Refractory to Supplemental Therapy with High Doses of Oral Calcium 489
Valutazione dell’insulino-sensibilità tramite clamp euglicemico iperinsulinemico in bambini in terapia sostitutiva con GH. 364
Predictors of microvascular complications in type 1 diabetic patients at onset: The role of metabolic memory 332
L’insulino-resistenza è il principale fattore indipendente correlato con l’aumentato rischio metabolico nelle donne affette da PCOS 288
Clinical and metabolic effects of first-line treatment with somatostatin analogues or surgery in acromegaly: a retrospective and comparative study 273
Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency 268
Alteration of the growth hormone axis, visceral fat dysfunction, and early cardiometabolic risk in adults: the role of the visceral adiposity index 268
Identification of Novel Wsf1 Mutations in a Sicilian Child with Wolfram Syndrome 266
Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS 258
Hepatic steatosis index in acromegaly: Correlation with insulin resistance regardless of the disease control 251
Commento a "Resistin, visfatin, leptin and omentin are differently related to hormonal and metabolic parameters in growth hormone-deficient children " 247
Diabete e complicanze materno-fetali in gravidanza: confronto tra pazienti con diabete tipo 1 e tipo 2 pregravidico. 242
GHD come predittore di sindrome metabolica 239
Cornea in acromegalic patients as a possible target of growth hormone action. 238
OCT is not useful for detection of minimal diabetic retinopathy in type 1 diabetes. 235
Early Lung Function Abnormalities in Acromegaly. 233
Janus kinase (JAK) 2 V617F mutation as the cause of primary thrombocythemia in acromegaly with severe visceromegaly and divergence between growth hormone and insulin-like growth factor-1 concentrations during the follow-up: causal or casual association? 232
Comparison between euglycemic hyperinsulinemic clamp and surrogate indices of insulin sensitivity in children with growth hormone deficiency 231
Circulating Irisin Levels in Children with GH Deficiency before and after 1 Year of GH Treatment 227
The degree of urinary hypercortisolism is not correlated with the severity of cushing’s syndrome 227
Visceral Adiposity Index Is Associated with Insulin Sensitivity and Adipocytokine Levels in Newly Diagnosed Acromegalic Patients. 225
Complete biochemical control and pituitary adenoma disappearance in a child with gigantism: efficacy of octreotide therapy 221
Clamp euglicemico iperinsulinemico e test al glucagone come utili strumenti di valutazione degli effetti metabolici della terapia sostitutiva con GH. 221
Dual-release hydrocortisone vs conventional glucocorticoids in adrenal insufficiency 215
Correlation between adrenal function, growth hormone secretion, and insulin sensitivity in children with idiopathic growth hormone deficiency 213
Commento a "The impact of real practice inappropriateness and devices' inefficiency to variability in growth hormone consumption" 213
Lacrimal glands herniation in patients with Graves’ Ophthalmopathy: an effective MRI-derived marker of disease activity 205
Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels. 204
Rivalutazione delle caratteristiche cliniche e metaboliche di bambini con deficit isolato di ormone della crescita durante il trattamento con GH secondo la modifica alla nota 39 AIFA 204
Il c-peptide come marker principale nella storia naturale del Diabete tipo 1: ruolo della funzione b-cellulare pancreatica nelle complicanze 203
Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients. 202
The metabolic outcomes of growth hormone treatment in children are gender specific 199
Relative Hypoleptinemia in poor controlled patients with Type 1 Diabetes 195
The Metabolic Profile in Active Acromegaly is Gender-Specific. 194
Is diabetes in Cushing's syndrome only a consequence of hypercortisolism? 191
Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance. 191
Insulin sensitivity and secretion and adipokine profile in patients with Cushing’s disease treated with pasireotide 191
Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study. 190
Improved insulin sensitivity and secretion in prediabetic patients with adrenal insufficiency on dual-release hydrocortisone treatment: a 36-month retrospective analysis 190
Systolic flow peak of inferior thyroid arteries in Graves’disease: A predictive parameter for the ophalmopathy development. 188
Difficoltà di identificazione della sindrome MEN2B ad esordio infantile: iter diagnostico. 187
Alterazioni del metabolismo glucidico determinate da eccesso di ormoni controregolatori: ruolo del GH 187
Resistin, visfatin, leptin and omentin are differently related to hormonal and metabolic parameters in growth hormone-deficient children 187
The visceral adiposity index is associated with insulin sensitivity and IGF-I levels in adults with growth hormone deficiency 187
Pasireotide versus pituitary surgery: a retrospective analysis of 12 months of treatment in patients with Cushing's disease 187
Growth hormone and hematopoiesis: A retrospective analysis on a large cohort of children with growth hormone deficiency 187
Corneal thickness in children with growth hormone deficiency: The effect of GH treatment. 185
Utility of C-peptide for a reliable estimate of insulin secretion in children with growth hormone deficiency. 179
Studio randomizzato controllato, della durata di 2 anni, sugli effetti e la sicurezza di differenti dosaggi di r-hGH, titolati sulla base dei livelli di IGF1 in pazienti con bassa statura in trattamento: considerazioni terapeutiche e farmacoeconomiche 179
No phenotypic differences for polycystic ovary syndrome (PCOS) between women with and without type 1 diabetes mellitus. 179
Changes in lipid profile and adipokine levels in GH deficient children during GH replacement therapy. 178
Vitamin D across growth hormone (GH) disorders: From GH deficiency to GH excess 178
Lacrimal gland herniation in Graves ophthalmopathy: a simple and useful MRI biomarker of disease activity 178
Glycometabolic control in Acromegalic patients with Diabetes: a study of the effects of different treatments for GH excess and for hyperglycaemia. 176
Correlation between Severity of Growth Hormone Deficiency and Thyroid Metabolism and Effects of Long-Term Growth Hormone Treatment on Thyroid Function in Children with Idiopathic Growth Hormone Deficiency. 176
Alte dosi di cabergolina migliorano i parametri metabolici in pazienti affetti da prolattinoma. 175
Adrenal incidentaloma: a new contributing factor in metabolic syndrome 174
Higher cardiometabolic risk in idiopathic versus autoimmune type 1 diabetes: A retrospective analysis 174
Alterazioni del metabolismo glucidico determinate da eccesso di ormoni contro regolatori. 170
Alta prevalenza di Sindrome dell’ovaio policistico in donne diabetiche di tipo 1 in età fertile. 170
The lacrimal gland herniation role in the Graves’ orbitopathy 170
Diabetes Secondary to Acromegaly: Physiopathology, Clinical Features and Effects of Treatment. 169
GH-suppression test in acromegaly: comparison between OGTT and chocolate test 167
Adrenal incidentaloma: a new contributing factor in metabolic syndrome? 167
Circulating adipokine levels in diabetic patients with Cushing disease on pasireotide treatment compared with patients with type 2 diabetes mellitus 167
Revaluation of the clinical and metabolic behavior of children with isolated growth hormone deficiency during GH treatment according to newly proposed note 39 of the Italian Medicines Agency (AIFA). 166
Leptina e adiponectina nella valutazione del compenso glicometabolico in corso di diabete mellito di tipo 1 normopeso. 165
No effect of GH/IGF-1 excess on adrenal glands in acromegalic patients 164
Buon compenso glicemico nei pazienti acromegalici affetti da diabete secondario. 164
Prevalence and clinical features of polycystic ovarian syndrome in adolescents with previous childhood growth hormone deficiency 164
Erratum to: Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study (Diabetes Therapy, (2018), 9, 1, (363-371), 10.1007/s13300-017-0338-4) 163
Decreased regulatory CD4+CD25+ Treg cells in newly diagnosed type 1 diabetes 161
Efficacy of combined treatment with pasireotide, pegvisomant and cabergoline in an acromegalic patient resistant to other treatments: a case report 159
Serum visfatin levels in acromegaly: Correlation with disease activity and metabolic alterations 158
Visceral Adipose function, insulin sensitivity and secretion in active acromegaly. 157
Iter diagnostico "rapido" per un caso di MEN IIb in un giovane adolescente 155
Pasireotide treatment reduces cardiometabolic risk in Cushing’s disease patients: an Italian, multicenter study 154
EFFECTS OF PASIREOTIDE TREATMENT ON CARDIOMETABOLIC RISK IN PATIENTS WITH CUSHING’S DISEASE : AN ITALIAN, MULTICENTER STUDY 150
Comparison of clinical and metabolic effects of pasireotide and pituitary surgery in Cushing disease 150
Reduction in insulin sensitivity and inadequate β-cell capacity to counteract the increase in insulin resistance in children with idiopathic growth hormone deficiency during 12 months of growth hormone treatment 148
Clinical and metabolic impact of three-times-weekly versus daily growth hormone (GH) treatment in naïve GH-deficient children 147
Maggiore rischio cardiometabolico in pazienti di razza non caucasica affetti da diabete mellito di tipo 1 idiopatico rispetto alla forma autoimmune in pazienti caucasici. 146
Increased central corneal thickness in acromegalic patients. 144
The adipose visceral dysfunction plays an important role in diabetes in Cushing disease. 141
Glucose metabolism in children with growth hormone deficiency 137
Miglioramento clinico e metabolico in pazienti affetti da diabete mellito tipo 1 associato ad altre endocrinopatie (APS) dopo shift della terapia insulinica basale con glargine a degludec 136
Adrenal morphology and function in acromegalic patients in relation to disease activity. 135
Il c-peptide come marker principale nella storia naturale del Diabete di tipo 1: ruolo della funzione b-cellulare pancreatica nelle complicanze. 132
La valutazione retinica mediante Tomografia a Coerenza Ottica (OCT) nel diabete mellito tipo 1. 132
IL CONSUMO DI BEVANDE RICCHE DI ACIDO ORTOFOSFORICO COME FATTORE DI RISCHIO PER LO SVILUPPO DI IPOCALCEMIA: IL CASO DI UNA DONNA CON IPOPARATIROIDISMO POST-CHIRURGICO 132
Improved cardiovascular and cardiometabolic risk in patients with type 1 diabetes and autoimmune polyglandular syndrome switched from glargine to degludec due to hypoglycaemic variability 132
GH-treatment improves growth and reduces the severity of fibrosis and hypertansaminasemia in a prepubertal child with sclerosant cholangiopathy 130
Effects of pasireotide treatment on coagulative profile: a prospective study in patients with Cushing’s disease 130
IPOVITAMINOSI D ED EFFETTI BENEFICI DELLA TERAPIA SOSTITUTIVA CON GH SUI LIVELLI DI VITAMINA D IN BAMBINI AFFETTI DA DEFICIT DI GH 126
Janus kinase (JAK) 2 V617F mutation as the cause of primary thrombocythemia, severe visceromegaly and divergence between growth hormone and insulin-like growth factor-1 concentrations in acromegaly due to a therapeutically resistant pituitary GH-secreting macroadenoma 125
High prevalence of hypovitaminosis D in Sicilian children affected by growth hormone deficiency and its improvement after 12 months of replacement treatment. 123
Poor diagnostic value of the euglycemic-hyperinsulinemic clamp in the clinical assessment of insulin resistant women with PCOS. 117
Impact of obesity, insulin resistance and hyperandrogenism on steatosis and fibrosis risk in young females with PCOS 117
Increated central corneal thickness in acromegalic patients 116
The relationship between metabolic syndrome and bone health: results of a retrospective gender specific female study. 116
Totale 18.888
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.476
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.476
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.382 51 250 49 62 70 70 41 80 143 190 81 295
2022/20231.537 183 229 24 160 172 250 132 103 163 13 78 30
2023/2024763 23 119 45 68 76 138 81 60 9 44 10 90
2024/20251.975 97 75 147 179 71 60 80 203 164 208 267 424
2025/20267.345 384 216 361 499 616 1.030 1.246 735 575 981 351 351
2026/2027354 354 0 0 0 0 0 0 0 0 0 0 0
Totale 21.491